The Community Guide

- gsearch

Search Results

Narrow Results:

2019 1
2018 1

Republic of Korea 1

Journal Article 2

1 - 2 of 2 Results

Refine Results

Refine Results:

Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial

CITE Title : Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial Personal Author(s) : Meya, David B.;Kiragga, Agnes N.;Nalintya, Elizabeth;Morawski, Bozena M.;Rajasingham, Radha;Park, Benjamin J.;Mubiru, Anthony;Kaplan, Jonathan E.;Manabe, Yukari C.;Boulware, David R.; Published Date : Feb 01 2019;2-1-; Source : J Acquir Immune Defic Syndr. 2018; 80(2):182-189 URL : https://stacks.cdc.gov/view/cdc/77380 Meya, David B. et al. (2019). Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial. 80(2). Meya, David B. et al. "Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial" 80, no. 2 (2019) Meya, David B. et al. "Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial" vol. 80, no. 2, 2019 Export RIS Citation Information.

:

Meya, David B. ;

Kiragga, Agnes N.

Feb 01 2019 | J Acquir Immune Defic Syndr. 2018; 80(2):182-189

:

Background:HIV-infected persons with cryptococcal antigenemia (CrAg) are at high risk for meningitis or death. We evaluated the effect of CrAg screeni...
Fluconazole-Resistant Candida parapsilosis Bloodstream Isolates with Y132F Mutation in ERG11 Gene, South Korea

CITE Title : Fluconazole-Resistant Candida parapsilosis Bloodstream Isolates with Y132F Mutation in ERG11 Gene, South Korea Personal Author(s) : Choi, Yong Jun;Kim, Yae-Jean;Yong, Dongeun;Byun, Jung-Hyun;Kim, Taek Soo;Chang, Yun Sil;Choi, Min Ji;Byeon, Seung Ah;Won, Eun Jeong;Kim, Soo Hyun;Shin, Myung Geun;Shin, Jong Hee; Published Date : Sep 2018 Source : Emerg Infect Dis. 24(9):1768-1770. URL : https://stacks.cdc.gov/view/cdc/58653 Choi, Yong Jun et al. (2018). Fluconazole-Resistant Candida parapsilosis Bloodstream Isolates with Y132F Mutation in ERG11 Gene, South Korea. 24(9). Choi, Yong Jun et al. "Fluconazole-Resistant Candida parapsilosis Bloodstream Isolates with Y132F Mutation in ERG11 Gene, South Korea" 24, no. 9 (2018) Choi, Yong Jun et al. "Fluconazole-Resistant Candida parapsilosis Bloodstream Isolates with Y132F Mutation in ERG11 Gene, South Korea" vol. 24, no. 9, 2018 Export RIS Citation Information.

:

Choi, Yong Jun ;

Kim, Yae-Jean

Sep 2018 | Emerg Infect Dis. 24(9):1768-1770.

:

We recently observed the emergence of fluconazole-resistant Candida parapsilosis bloodstream isolates harboring a Y132F substitution in Erg11p in Sout...